Welcome to GENESIS Hangzhou!

page_banner

product

OEM/ODM Manufacturer Antigen Rapid Test Device Saliva - KaiBiLi COVID-19 Antigen (Professional) – Genesis


Product Detail

Related Video

Feedback (2)

We keep improving and perfecting our products and service. At the same time, we work actively to do research and development for Covid-19 Antigen -Saliva Cup, Zn Stain, Throat Swab Specimen Collection, Our products enjoy good popularity among our customers. We welcome customers, business associations and friends from all parts of the world to contact us and seek cooperation for mutual benefits.
OEM/ODM Manufacturer Antigen Rapid Test Device Saliva - KaiBiLi COVID-19 Antigen (Professional) – Genesis Detail:

Introduction

COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main symptoms including manifestations include fever, fatigue and dry cough, nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.

The KaiBiLiTM COVID-19 Antigen Rapid Test Device is an in vitro diagnostic test based on the principle of immunochromatography for the qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in nasal swab or nasopharyngeal swab. The detection is based on the antibodies which were developed specifically recognizing and reacting with the nucleoprotein of 2019 Novel Coronavirus. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infection.

This assay is intended for rapid screening in laboratory. This test should be conducted by trained technician, wearing appropriate personal protective equipment (PPE). 

Detection

The qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in nasal swab or nasopharyngeal swab.

Specimen

Nasal or Nasopharyngeal 

Limit of Detection (LoD)

SARS-CoV-2: 140 TCID50/mL

Accuracy(Nasal swab)

Positive Percent Agreement: 96.6%

Negative Percent Agreement:100%

Overall Percent Agreement: 98.9%

Accuracy (Nasopharyngeal swab)

Positive Percent Agreement: 97.0%

Negative Percent Agreement:98.3%

Overall Percent Agreement: 97.7%

Time to Results

Read results at 15minutes and no more than 30 minutes. 

Kit storage conditions

2~30°C. 

Contents

Description

Qty

COVID-19 antigen test devices

20

Sterilized swabs

20

Extraction tubes (with 0.5mL extraction buffer)

20

Nozzles with filter

20

Tube Stand

1

Package Insert

1

Ordering Information

Product

Cat.No.

Contents

KaiBiLiTM COVID-19 Antigen 

P211139

20 Tests


Product detail pictures:

OEM/ODM Manufacturer Antigen Rapid Test Device Saliva - KaiBiLi COVID-19 Antigen (Professional) – Genesis detail pictures

OEM/ODM Manufacturer Antigen Rapid Test Device Saliva - KaiBiLi COVID-19 Antigen (Professional) – Genesis detail pictures


Related Product Guide:

We are also focusing on enhancing the things administration and QC program in order that we could keep fantastic advantage within the fiercely-competitive enterprise for OEM/ODM Manufacturer Antigen Rapid Test Device Saliva - KaiBiLi COVID-19 Antigen (Professional) – Genesis , The product will supply to all over the world, such as: Luxembourg, Romania, Casablanca, We strive for excellence, constant improvement and innovation, is committed to make us the "customer trust" and the "first choice of engineering machinery accessories brand" suppliers. Choose us, sharing a win-win situation!
Wide range, good quality, reasonable prices and good service, advanced equipment, excellent talents and continuously strengthened technology forces,a nice business partner.
5 Stars By Victoria from Finland - 2017.11.12 12:31
This enterprise in the industry is strong and competitive, advancing with the times and develop sustainable, we are very pleased to have a opportunity to cooperate!
5 Stars By Caroline from Sri Lanka - 2017.06.29 18:55
Write your message here and send it to us